Comparability preview
Build the board report — $49 →
The Myelodysplastic Syndromes Foundation
EIN 223283911 · NY · NTEE G30 · revenue $2,002,126 · FY 2024-12-31
$
Pick the role and type the pay your board is considering — everything below updates as you type. We only compare against the same role.
48th percentile
We compared this Executive Director / CEO's pay to 42 similar diseases & disorders nonprofits of about the same size, adjusted for NY cost of living and inflation.
TRACEY IRACA · reported title "EXECUTIVE DIRECTOR (THROUGH 1/25)".
How we chose them
Every comparable organization in the band — 42 in total — matched by Same NTEE sector (G30), nationwide + budget 0.71–1.4× revenue, and selected by rule, not hand-picked. Peer pay is normalized to NY cost of living (BEA Regional Price Parities) and to the subject's filing year (CPI-U). Full methodology →
| Organization | State | Revenue | Total comp | Filing |
|---|---|---|---|---|
| The Ulman Cancer Fund For Young Adults | MD | $2,020,014 | $215,648 | 990 → |
| Promise Fund Of Florida Inc | FL | $1,969,548 | $191,947 | 990 → |
| Julie Rogers Gift Of Life Program | TX | $1,964,374 | $112,216 | 990 → |
| Cancer Support Team Inc | NY | $1,942,613 | $162,011 | 990 → |
| Little Red Door Cancer Agency Inc | IN | $1,934,459 | $157,711 | 990 → |
| 🔒 +37 more comparable organizations — the full peer set, sources, and CSV export are included in your board report. | ||||
Generate the board-ready determination
A formatted PDF with the full 42-organization peer set, the distribution, the methodology, and ready-to-adopt 26 CFR 53.4958-6 board-minutes language — timestamped to attach to your minutes. A screenshot of a webpage isn't board minutes.